viral vectors
viral vectors
Revolutionizing Viral Vector Production for Advanced Therapies!
Unlock advanced therapies in gene treatments! 🌟 Overcome manufacturing challenges with Cytiva's ELEVECTA™. 💡 Collaboration is key! 🛠️ HealthcareInnovation
MilliporeSigma Boosts Gene Therapy with $600M Acquisition!
MilliporeSigma acquires Mirus Bio for $600 million, boosting viral vector manufacturing and supporting gene therapy advancements! 🚀🔬💡🤝
Boosting Biopharma Confidence with Cutting-Edge Tools
🧪 Charles River Laboratories: Tools & services for efficient production & testing of cell, gene, & gene-modified therapy products. 🔬 Reference materials for assay development & validation. 🧬 Technology transfer & Flex Platform for cell therapy development. 💪 Accelerating new therapies with consistency & confidence.
Revolutionary Cell Manufacturing Lines for Gene Therapies: Cytiva’s Game-Changing Solution
📢 Cytiva introduces new cell manufacturing lines for viral vectors in gene therapies, aiming to standardize manufacturing and reduce costs. 💼💡🔬🚀
Game-changing Partnership: Naobios and Sumagen Unite to Tackle HIV Vaccine Challenge
🌍 Naobios and Sumagen join forces to develop an HIV vaccine, using cutting-edge bioprocess and viral vector technology. 🧬🔬
Gene Therapy Supplier Raises £7M for Breakthrough Technology
💰 Gene therapy supplier MIP Discovery secures £7M in funding to boost commercialization of synthetic affinity reagents in cell and gene therapy. 🧬🔬👥
UK Accelerates Biologic Manufacturing with Next-Gen Therapies
📰 The U.K. is leading the way in biologic manufacturing, investing in cutting-edge therapies and advanced analytical technologies. 🇬🇧💉
